Lung cancer combo trial halted early after just 9 patients
NCT ID NCT02257619
First seen Apr 24, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study tested whether adding the experimental drug itacitinib to standard chemotherapy (docetaxel) could help people with advanced non-small cell lung cancer live longer. The trial was designed for patients who had already tried one prior treatment. However, the study was stopped early and only enrolled 9 participants, so no clear conclusions can be drawn about the combination's effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CARCINOMA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Hot Springs, Arizona, United States
-
Study site
Los Angeles, California, United States
-
Study site
Washington D.C., District of Columbia, United States
-
Study site
Orlando, Florida, United States
-
Study site
Detroit, Michigan, United States
-
Study site
Pascagoula, Mississippi, United States
-
Study site
Kansas City, Missouri, United States
-
Study site
Omaha, Nebraska, United States
-
Study site
Lebanon, New Hampshire, United States
-
Study site
Goldsboro, North Carolina, United States
-
Study site
Cleveland, Ohio, United States
-
Study site
Gettysburg, Pennsylvania, United States
-
Study site
Hershey, Pennsylvania, United States
-
Study site
Pawtucket, Rhode Island, United States
-
Study site
Spartanburg, South Carolina, United States
-
Study site
Round Rock, Texas, United States
Conditions
Explore the condition pages connected to this study.